The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Open accessAbstract
As the concentrations of highly consumed nutrients, particularly glucose, are generally lower in tumours than in normal tissues, cancer cells must adapt their metabolism to the tumour microenvironment. A better understanding of these adaptations might reveal cancer cell liabilities that can be exploited for therapeutic benefit. Here we developed a continuous-flow culture apparatus (Nutrostat) for maintaining proliferating cells in low-nutrient media for long periods of time, and used it to undertake competitive proliferation assays on a pooled collection of barcoded cancer cell lines cultured in low-glucose conditions. Sensitivity to low glucose varies amongst cell lines, and an RNA interference (RNAi) screen pinpointed mitochondrial oxidative phosphorylation (OXPHOS) as the major pathway required for optimal proliferation in low glucose. We found that cell lines most sensitive to low glucose are defective in the OXPHOS upregulation that is normally caused by glucose limitation as a result of either mitochondrial DNA (mtDNA) mutations in complex I genes or impaired glucose utilization. These defects predict sensitivity to biguanides, antidiabetic drugs that inhibit OXPHOS, when cancer cells are grown in low glucose or as tumour xenografts. Notably, the biguanide sensitivity of cancer cells with mtDNA mutations was reversed by ectopic expression of yeast NDI1, a ubiquinone oxidoreductase that allows bypass of complex I function. Thus, we conclude that mtDNA mutations and impaired glucose utilization are potential biomarkers for identifying tumours with increased sensitivity to OXPHOS inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These findings confirm previous studies that analyzed inhibition of either glycolysis or OXPHOS, and observed an increase in the activity of the other pathway (Hao et al., 2010; Jose et al., 2011; Birsoy et al., 2014; Dykens et al., 2008).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“Cancer cells with reduced OXPHOS due to either mutated mitochondrial DNA or impaired glucose utilization were unable to initiate this adaptive response, and were thus particularly sensitive to glucose deprivation to one-tenth of normal levels (Birsoy et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
In the citing paper
“These results are consistent with previous studies reporting the synergism of the metformin/low glucose combination (Birsoy et al., 2014; Zhuang et al., 2014).”
From Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3β-MCL-1 Axis (2019) · cites this paper as Birsoy et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Possemato, R., Marks, K. M., Shaul, Y. D., Pacold, M. E., Kim, D., Birsoy, K., Sethumadhavan, S., Woo, H.-K., Jang, H. G., Jha, A. K., et al. (2011) · Nature · doi:10.1038/nature10350 · Cited by 1,683
Self-citationMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A. L., Kafri, R., Kirschner, M. W., Clish, C. B., & Mootha, V. K. (2012) · Science · doi:10.1126/science.1218595 · Cited by 1,403
Self-citationEl-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Hirayama, A., Kami, K., Sugimoto, M., Sugawara, M., Toki, N., Onozuka, H., Kinoshitá, T., Saito, N., Ochiai, A., Tomita, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4806 · Cited by 965
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
DeCensi, A., Puntoni, M., Goodwin, P., Cazzaniga, M., Gennari, A., Bonanni, B., & Gandini, S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0157 · Cited by 918
Observations on the carbohydrate metabolism of tumours
Crabtree, H. G. (1929) · Biochemical Journal · doi:10.1042/bj0230536 · Cited by 864
Cited by
Sorted by citations
Items 101–200 of 710
Mitochondrial complex I promotes kidney cancer metastasis
Bezwada, D., Perelli, L., Lesner, N. P., Cai, L., Brooks, B., Wu, Z., Vu, H., Sondhi, V., Cassidy, D. L., Kasitinon, S. Y., et al. (2024) · Nature · doi:10.1038/s41586-024-07812-3 · Cited by 158
Senkowski, W., Zhang, X., Olofsson, M. H., Isacson, R., Höglund, U., Gustafsson, M. G., Nygren, P., Linder, S. T., Larsson, R. L., & Fryknäs, M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0792 · Cited by 144
Metabolic features of cancer stem cells: the emerging role of lipid metabolism
Mancini, R., Noto, A., Pisanu, M. E., Vitis, C. D., Maugeri‐Saccà, M., & Ciliberto, G. (2018) · Oncogene · doi:10.1038/s41388-018-0141-3 · Cited by 140
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 147
Orecchioni, S., Reggiani, F., Talarico, G., Mancuso, P., Calleri, A., Gregato, G., Labanca, V., Noonan, D. M., Dallaglio, K., Albini, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29193 · Cited by 148
A framework for examining how diet impacts tumour metabolism
Lien, E. C., & Vander Heiden, M. G. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0198-5 · Cited by 139
Serine deprivation enhances antineoplastic activity of biguanides
Gravel, S.-P., Hulea, L., Toban, N., Birman, E., Blouin, M.-J., Zakikhani, M., Zhao, Y., Topisirovic, I., St-Pierre, J., & Pollak, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2643-t · Cited by 138
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Gomes, A. S., Ramos, H., Soares, J., & Saraiva, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.015 · Cited by 143
Barbosa, A. M., & Martel, F. (2020) · Cancers · doi:10.3390/cancers12010154 · Cited by 140
Biological insights through nontargeted metabolomics
Sévin, D. C., Kuehne, A., Zamboni, N., & Sauer, U. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.10.001 · Cited by 141
Lord, S., Cheng, W., Liu, D., Gaude, E., Haider, S. A., Metcalf, T., Patel, N., Teoh, E., Gleeson, F. V., Bradley, K. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.021 · Cited by 136
Functional genomics in vivo reveal metabolic dependencies of pancreatic cancer cells
Zhu, X. G., Chudnovskiy, A., Baudrier, L., Prizer, B., Liu, Y., Ostendorf, B. N., Yamaguchi, N., Arab, A., Tavora, B., Timson, R., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.017 · Cited by 130
Self-citationThe α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity
Vatrinet, R., Leone, G., Luise, M. D., Girolimetti, G., Vidone, M., Gasparre, G., & Porcelli, A. M. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0165-0 · Cited by 133
Precancer Atlas to Drive Precision Prevention Trials
Spira, A. E., Yurgelun, M. B. B., Alexandrov, L. B., Rao, A., Bejar, R., Polyák, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 135
Metformin, cancer and glucose metabolism
Salani, B., Río, A. D., Marini, C., Sambuceti, G., Cordera, R., & Maggi, D. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0284 · Cited by 129
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
Lord, S., & Harris, A. L. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02204-2 · Cited by 139
Cell Culture Medium Formulation and Its Implications in Cancer Metabolism
Ackermann, T., & Tardito, S. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.05.004 · Cited by 126
Oshima, N., Ishida, R., Kishimoto, S., Beebe, K. E., Brender, J., Yamamoto, K., Urban, D. J., Rai, G., Johnson, M. S., Benavides, G. A., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.039 · Cited by 131
Senkowski, W., Gall-Mas, L., Falco, M. M., Li, Y., Lavikka, K., Kriegbaum, M. C., Oikkonen, J., Bulanova, D. R., Pietras, E. J., Voßgröne, K., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.04.012 · Cited by 128
Gritti, M., Würth, R., Angelini, M., Barbieri, F., Peretti, M., Pizzi, E., Pattarozzi, A., Carra, E., Sirito, R., Daga, A., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2617 · Cited by 126
Jin, X., Chen, C., Liu, R., Gou, D., Chang, L., Deng, H., Gao, Q., Zhang, W., Tuo, L., Pan, X., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci144703 · Cited by 121
Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 124
Sun, L., Wan, A. H., Zhou, Z., Chen, D., Liang, H., Liu, C., Yan, S., Niu, Y., Lin, Z., Zhan, S., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-320652 · Cited by 117
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Zhao, Z., Mei, Y., Wang, Z., & He, W. (2022) · Cancers · doi:10.3390/cancers15010062 · Cited by 128
Zarei, M., Lal, S., Parker, S. J., Nevler, A., Gohar, A. V., Dukleska, K., Mambelli-Lisboa, N. C., Moffat, C., Blanco, F. F., Chand, S. N., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0015 · Cited by 119
Pollak, M. (2014) · Nature Medicine · doi:10.1038/nm.3596 · Cited by 115
Energy disruptors: rising stars in anticancer therapy?
Bost, F., Poullot, A. G., Tanti, J., & Clavel, S. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.46 · Cited by 119
Mechanism and application of metformin in kidney diseases: An update
Song, A., Zhang, C., & Meng, X. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111454 · Cited by 122
Different effects of LDH-A inhibition by oxamate in non-small cell lung cancer cells
Yang, Y., Su, D., Zhao, L., Zhang, D., Xu, J., Wan, J., Fan, S., & Chen, M. (2014) · Oncotarget · doi:10.18632/oncotarget.2620 · Cited by 116
Urine Metabolic Fingerprints Encode Subtypes of Kidney Diseases
Yang, J., Wang, R., Huang, L., Zhang, M., Niu, J., Bao, C., Shen, N., Dai, M., Guo, Q., Wang, Q., et al. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201913065 · Cited by 114
Insights into the Link Between Obesity and Cancer
Ackerman, S. E., Blackburn, O. A., Marchildon, F., & Cohen, P. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0263-x · Cited by 122
Aregger, M., Lawson, K. A., Billmann, M., Costanzo, M., Tong, A. H. Y., Chan, K., Rahman, M., Brown, K. R., Ross, C., Usaj, M., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0211-z · Cited by 115
Bayraktar, E. C., Baudrier, L., Özerdem, C., Lewis, C. A., Chan, S. H., Kunchok, T., Abu-Remaileh, M., Cangelosi, A. L., Sabatini, D. M., Birsoy, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816656115 · Cited by 111
Self-citationAIF-regulated oxidative phosphorylation supports lung cancer development
Rao, S., Mondragón, L., Pranjic, B., Hanada, T., Stoll, G., Köcher, T., Zhang, P., Jaïs, A., Lercher, A., Bergthaler, A., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0181-4 · Cited by 115
Lactate and Acidity in the Cancer Microenvironment
Parks, S. K., Mueller‐Klieser, W., & Pouysségur, J. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033556 · Cited by 115
Xintaropoulou, C., Ward, C., Wise, A., Queckbörner, S., Turnbull, A., Michie, C. O., Williams, A. R. W., Rye, T., Gourley, C., & Langdon, S. P. (2018) · BMC Cancer · doi:10.1186/s12885-018-4521-4 · Cited by 107
Zhang, F., Liu, H., Duan, M., Wang, G., Zhang, Z., Wang, Y., Qian, Y., Yang, Z., & Jiang, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01304-5 · Cited by 111
Genini, D., Brambilla, L., Laurini, E., Merulla, J., Civenni, G., Pandit, S., D'Antuono, R., Perez, L., Levy, D. E., Pricl, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615730114 · Cited by 106
CHP1 Regulates Compartmentalized Glycerolipid Synthesis by Activating GPAT4
Zhu, X. G., Nicholson, S. P. V., Shen, Y., La, K., Özlü, C., Wang, T., Klompstra, D., Gültekin, Y., Chi, J., Fidelin, J., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.037 · Cited by 108
Self-citationLi, C., Wan, Y., Zhang, Y., Fu, L., Blum, N. T., Cui, R., Wu, B., Zheng, R., Lin, J., Li, Z., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103980 · Cited by 105
Self‐Propelled Micro/Nanomotors for Tumor Targeting Delivery and Therapy
Lin, R., Yu, W., Chen, X., & Gao, H. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001212 · Cited by 106
Electron transport chain inhibition increases cellular dependence on purine transport and salvage
Wu, Z., Bezwada, D., Cai, F., Harris, R. C., Ko, B., Sondhi, V., Pan, C., Vu, H., Nguyen, P. T., Faubert, B., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.014 · Cited by 105
Metformin: A Novel Biological Modifier of Tumor Response to Radiation Therapy
Koritzinsky, M. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.06.003 · Cited by 103
Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism
Gatto, F., Miess, H., Schulze, A., & Nielsen, J. (2015) · Scientific Reports · doi:10.1038/srep10738 · Cited by 99
Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism
Kim, J. H., Lee, K. J., Seo, Y., Kwon, J.-H., Yoon, J. P., Kang, J. Y., Lee, H. J., Park, S. J., Hong, S. P., Cheon, J. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18762-4 · Cited by 104
GLUT1 protects prostate cancer cells from glucose deprivation-induced oxidative stress
González‐Menéndez, P., Hevia, D., Alonso‐Arias, R., Álvarez-Artime, A., Rodríguez‐García, A., Kinet, S., Gonzalez‐Pola, I., Taylor, N. N., Mayo, J. C., & Sainz, R. M. (2018) · Redox Biology · doi:10.1016/j.redox.2018.03.017 · Cited by 103
Philip, P. A., Buyse, M. E., Alistar, A. T., Lima, C. M. S. R., Luther, S., Pardee, T. S., & Cutsem, E. V. (2019) · Future Oncology · doi:10.2217/fon-2019-0209 · Cited by 101
An LKB1–mitochondria axis controls TH17 effector function
Baixauli, F., Piletič, K., Puleston, D. J., Villa, M., Field, C. S., Flachsmann, L. J., Quintana, A., Rana, N., Edwards-Hicks, J., Matsushita, M., et al. (2022) · Nature · doi:10.1038/s41586-022-05264-1 · Cited by 102
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis
Palorini, R., Votta, G., Pirola, Y., Vitto, H. D., Palma, S. D., Airoldi, C., Vasso, M., Ricciardiello, F., Lombardi, P. P., Cirulli, C., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005931 · Cited by 97
Luo, F., Zou, Z., Liu, X., Ling, M., Wang, Q., Wang, Q., Lu, L., Shi, L., Liu, Y., Liu, Q., et al. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx034 · Cited by 94
Stable heteroplasmy at the single-cell level is facilitated by intercellular exchange of mtDNA
Jayaprakash, A. D., Benson, E. K., Gone, S., Liang, R. H.-S., Shim, J. V., Lambertini, L., Toloue, M., Wigler, M., Aaronson, S. A., & Sachidanandam, R. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv052 · Cited by 94
Metformin prevents against oxidative stress-induced senescence in human periodontal ligament cells
Kuang, Y., Hu, B., Ge, F., Xiang, M., Deng, Y., Tan, M., Li, J., & Song, J. (2019) · Biogerontology · doi:10.1007/s10522-019-09838-x · Cited by 94
O’Brien, A. J., Villani, L. A., Broadfield, L. A., Houde, V. P., Galić, S., Blandino, G., Kemp, B. E., Tsakiridis, T. K., Muti, P. C., & Steinberg, G. R. (2015) · Biochemical Journal · doi:10.1042/bj20150122 · Cited by 90
Kaymak, I., Maier, C. R., Schmitz, W., Campbell, A. D., Dankworth, B., Ade, C. P., Walz, S., Paauwe, M., Kalogirou, C., Marouf, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0650 · Cited by 91
Roh, J., Park, J. Y., Kim, E. H., Jang, H. J., & Kwon, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.023 · Cited by 89
PGK1 Drives Hepatocellular Carcinoma Metastasis by Enhancing Metabolic Process
Xie, H., Tong, G., Zhang, Y., Liang, S., Tang, K., & Yang, Q. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081630 · Cited by 86
Pleiotropic Effects of Metformin on Cancer
Schulten, H.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102850 · Cited by 87
Metabolic Dependencies in Pancreatic Cancer
Gohar, A. V., Zarei, M., Brody, J. R., & Winter, J. M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00617 · Cited by 87
Cederquist, G., Tchieu, J. H., Callahan, S. J., Ramnarine, K., Ryan, S. D., Zhang, C., Rittenhouse, C. A., Zeltner, N., Chung, S. Y., Zhou, T., et al. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.06.004 · Cited by 89
Macrophage proliferation, provenance, and plasticity in macroparasite infection
Rückerl, D., & Allen, J. E. (2014) · Immunological Reviews · doi:10.1111/imr.12221 · Cited by 87
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
Harris, R. A., Tindale, L. C., & Cumming, R. C. (2014) · Biogerontology · doi:10.1007/s10522-014-9534-z · Cited by 86
Gohar, A. V., Cassel, J. A., Mohammed, F. S., Zarei, M., Hue, J. J., Hajihassani, O., Graor, H. J., Srikanth, Y. V. V., Karim, S. A., Abbas, A., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00393-y · Cited by 89
Mitochondrial dysfunction in cancer chemoresistance
Guaragnella, N., Giannattasio, S., & Moro, L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.027 · Cited by 87
Nicolay, B., Danielian, P. S., Kottakis, F., Lapek, J. D., Sanidas, I., Miles, W. O., Dehnad, M., Tschöp, K., Gierut, J. J., Manning, A. L., et al. (2015) · Genes & Development · doi:10.1101/gad.264127.115 · Cited by 84
Tuo, L., Xiang, J., Pan, X., Hu, J., Tang, H., Liang, L., Xia, J., Hu, Y., Zhang, W., Huang, A., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1029-y · Cited by 84
Mitochondria-targeted drugs for diabetic kidney disease
Mima, A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e08878 · Cited by 87
Nature and Nurture: What Determines Tumor Metabolic Phenotypes?
Mayers, J. R., & Heiden, M. G. V. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0165 · Cited by 86
Lin, S., Huang, C., Gunda, V., Sun, J., Chellappan, S., Li, Z., Izumi, V., Fang, B., Koomen, J. M., Singh, P. K., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.011 · Cited by 82
The gate to metastasis: key players in cancer cell intravasation
Sznurkowska, M. K., & Aceto, N. (2021) · FEBS Journal · doi:10.1111/febs.16046 · Cited by 86
Metabolic Profiles Associated With Metformin Efficacy in Cancer
Andrzejewski, S., Siegel, P. M., & St‐Pierre, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00372 · Cited by 85
Shangguan, F., Zhou, H., Ma, N., Wu, S., Huang, H., Jin, G., Wu, S., Hong, W., Zhuang, W., Xia, H., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.697832 · Cited by 84
Yang, Y., Chong, Y., Chen, M., Dai, W., Zhou, X., Ji, Y., Qiu, G., & Du, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02825-2 · Cited by 82
Metabolic pathway analysis using stable isotopes in patients with cancer
Bartman, C., Faubert, B., Rabinowitz, J. D., & DeBerardinis, R. J. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00632-z · Cited by 93
GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy
Shi, Y., Kotchetkov, I. S., Dobrin, A., Hanina, S., Rajasekhar, V. K., Healey, J. H., & Sadelain, M. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.05.006 · Cited by 86
Selective Inhibition of Deactivated Mitochondrial Complex I by Biguanides
Matsuzaki, S., & Humphries, K. M. (2015) · Biochemistry · doi:10.1021/bi501473h · Cited by 80
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Jeong, S., Savino, A. M., Chirayil, R., Barin, E., Cheng, Y., Park, S., Schurer, A., Mullarky, E., Cantley, L. C., Kharas, M. G., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.005 · Cited by 79
Modica-Napolitano, J. S., & Weissig, V. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817394 · Cited by 80
Tesori, V., Piscaglia, A. C., Samengo, D., Barba, M., Bernardini, C., Scatena, R., Pontoglio, A., Castellini, L., Spelbrink, J. N., Maulucci, G., et al. (2015) · Scientific Reports · doi:10.1038/srep09149 · Cited by 80
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways
Kim, S. M., Roy, S. G., Chen, B., Nguyen, T. M., McMonigle, R. J., McCracken, A. N., Zhang, Y., Kofuji, S., Hou, J., Selwan, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci87148 · Cited by 77
Sripada, L., Singh, K., Lipatova, A. V., Singh, A., Prajapati, P., Tomar, D., Bhatelia, K., Roy, M., Singh, R. K., Godbole, M. M., et al. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1517-5 · Cited by 79
Fresquet, V., Garcia-Barchino, M. J., Larráyoz, M., Celay, J., Vicente, C., Fernández‐Galilea, M., Larráyoz, M. J., Calasanz, M. J., Panizo, C., Junza, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1065 · Cited by 77
FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion
Li, S., Han, S., Zhang, Q., Zhu, Y., Zhang, H., Wang, J., Zhao, Y., Zhao, J., Su, L., Li, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31187-6 · Cited by 79
Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
Groenendijk, F. H., Mellema, W. W., van der Burg, E., Schut, E., Hauptmann, M., Horlings, H. M., Willems, S. M., van den Heuvel, M. M., Jonkers, J., Smit, E. F., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29113 · Cited by 76
lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1
Liu, X., & Gan, B. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1249545 · Cited by 77
Phenolic compound ellagic acid inhibits mitochondrial respiration and tumor growth in lung cancer
Duan, J., Li, Y., Gao, H., Yang, D., He, X., Fang, Y., & Zhou, G. (2020) · Food & Function · doi:10.1039/d0fo01177k · Cited by 75
Mnatsakanyan, N., & Jonas, E. A. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.013 · Cited by 76
Kumar, V., Kukkar, D., Hashemi, B., Kim, K., & Deep, A. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807859 · Cited by 74
Olszewski, K. L., Barsotti, A. M., Feng, X., Momcilovic, M., Liu, K. G., Kim, J., Morris, K., Lamarque, C., Gaffney, J., Yu, X., et al. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.10.007 · Cited by 79
ATP-exhausted nanocomplexes for intratumoral metabolic intervention and photoimmunotherapy
Yu, M., Zeng, W., Ouyang, Y., Liang, S. M., Yi, Y., Hao, H., Yu, J., Liu, Y., Nie, Y., Wang, T., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121503 · Cited by 75
Self-citationIron chelators target both proliferating and quiescent cancer cells
Fryknäs, M., Zhang, X., Bremberg, U., Senkowski, W., Olofsson, M. H., Brandt, P., Persson, I., D’Arcy, P., Gullbo, J., Nygren, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38343 · Cited by 81
Yaribeygi, H., Atkin, S. L., Pirro, M., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27699 · Cited by 71
Mitochondria-centric bioenergetic characteristics in cancer stem-like cells
Shin, M., & Cheong, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01127-y · Cited by 71
Targeting glucose uptake with siRNA-based nanomedicine for cancer therapy
Xu, C., Liu, Y., Shen, S., Zhu, Y., & Wang, J. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.01.068 · Cited by 71
An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis
Zhu, Y., da Silva, S. R., He, M., Liang, Q., Lu, C., Feng, P., Jung, J. U., & Gao, S. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005648 · Cited by 70
Forrest, M. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/025197 · Cited by 74
Old drug, new trick: Repurposing metformin for gynecologic cancers?
Febbraro, T., Lengyel, E. R., & Romero, I. L. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.10.011 · Cited by 71
Karslake, J., Maltas, J., Brumm, P., & Wood, K. B. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005098 · Cited by 71
Lahiguera, Á., Hyroššová, P., Figueras, A., Garzón, D., Moreno‐Justicia, R., Soto‐Cerrato, V., McNeish, I. A., Serra, V., Lázaro, C., Barretina-Ginesta, M.-P., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911217 · Cited by 79
The Mechanism of Action of Biguanides: New Answers to a Complex Question
Magno, L. D., Pastena, F. D., Bordone, R., Coni, S., & Canettieri, G. (2022) · Cancers · doi:10.3390/cancers14133220 · Cited by 81
Attacking the supply wagons to starve cancer cells to death
Selwan, E. M., Finicle, B. T., Kim, S. M., & Edinger, A. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12121 · Cited by 73
Metadata
- Authors
- Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M.
- Affiliations
- Broad Institute (US)
- Whitehead Institute for Biomedical Research (US)
- Corresponding author
- Sabatini, David M.
- ORCID
- Venue
- Nature
- Published
- 2014-03-16
- Volume
- 508
- Issue
- 7494
- Pages
- 108-112
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4012432
- OpenAlex
- W2104696999
- Cited by
- 710
- References
- 27
- Citations by year
- 2026: 17 · 2025: 44 · 2024: 58 · 2023: 46 · 2022: 60 · 2021: 75 · 2020: 83 · 2019: 71 · 2018: 51 · 2017: 49 · 2016: 61 · 2015: 59 · 2014: 35
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (CA129105, K99CA168940, CA103866, R01CA103866, R01CA129105, R00CA168940)
- National Institute of General Medical Sciences (T32GM007287)
- National Institute of Allergy and Infectious Diseases (AI-07389, T32AI007389)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK043351)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- glucose limitation, biguanides, mitochondrial oxidative phosphorylation, cancer metabolism, mitochondrial DNA mutations, complex I, antidiabetic drugs, OXPHOS inhibitors, continuous flow culture, tumor microenvironment, NDI1, glucose utilization, cancer cell lines, drug sensitivity biomarkers
- MeSH terms
- Adenosine Triphosphate, Animals, Biguanides, Culture Media, DNA, Mitochondrial, Glucose, Humans, Hypoglycemic Agents, Male, Mitochondria, Mutation, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Phenformin, Cell Culture Techniques, Xenograft Model Antitumor Assays, Saccharomyces cerevisiae Proteins, RNA Interference, Electron Transport Complex I, Cell Line, Tumor, Cell Proliferation, Mice, Molecular Typing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
